Multiciliate cells function prominently in the respiratory system, brain ependyma and female reproductive tract to produce vigorous fluid flow along epithelial surfaces. These specialized cells form during development when epithelial progenitors undergo an unusual form of ciliogenesis, in which they assemble and project hundreds of motile cilia. Notch inhibits multiciliate cell formation in diverse epithelia, but how progenitors overcome lateral inhibition and initiate multiciliate cell differentiation is unknown. Here we identify a coiled-coil protein, termed multicilin, which is regulated by Notch and highly expressed in developing epithelia where multiciliate cells form. Inhibiting multicilin function specifically blocks multiciliate cell formation in Xenopus skin and kidney, whereas ectopic expression induces the differentiation of multiciliate cells in ectopic locations. Multicilin localizes to the nucleus, where it directly activates the expression of genes required for multiciliate cell formation, including foxj1 and genes mediating centriole assembly. Multicilin is also necessary and sufficient to promote multiciliate cell differentiation in mouse airway epithelial cultures. These findings indicate that multicilin initiates multiciliate cell differentiation in diverse tissues, by coordinately promoting the transcriptional changes required for motile ciliogenesis and centriole assembly.
Cilia are microtubule-based organelles that project from the cell surface, and in vertebrates have diversified into structurally different subtypes 1 . Primary cilia are generally short, immotile, and extended by a variety of cell types as a means to sense mechanical and chemical stimuli. Motile cilia are extended by specialized epithelial cells and used to generate fluid flow along their surfaces. Cilium diversity enables vertebrate cells to carry out specialized functions and is one factor underlying the spectrum of phenotypes observed in human ciliopathies 1 . How cilium diversity is generated is an important problem in organelle biogenesis, and a poorly understood aspect of cell type differentiation.
Cilium diversity arises in part through the differential expression of components required for cilium subtype differentiation. Foxj1, a winged-helix transcription factor, exemplifies this mechanism by activating gene expression required for motile cilia formation 2 . Motile cilia first appear in the embryo when node cells extend a single cilium to generate a flow that establishes left-right asymmetry 3 . Motile cilia also form during organogenesis by multiciliate cells (MCCs) that differentiate within the respiratory airways, ependyma and oviduct 4 . In Foxj1 mutants, primary cilia are unaffected, but cilia formation is disrupted in both MCCs and the cells mediating left-right patterning [5] [6] [7] [8] . In gain-of-function experiments, Foxj1 is sufficient to induce the formation of an ectopic motile monocilium 7, 8 . Thus, Foxj1 activates repressed by Notch, and thus likely to promote MCC differentiation. The top gene in this comparison encodes a small coiled-coil protein that we have termed multicilin (MCI) for the reasons discussed below. MCI is the Xenopus orthologue of human IDAS, a protein related to the cell-cycle regulators GMNN and GEMC1 ( Supplementary Fig. S1a ; refs [14] [15] [16] . MCI is encoded in a region of the X. tropicalis genome that is syntenic to mammalian genomes containing MCI orthologues and flanked by CCNO and CDC20B. CCNO is functionally uncharacterized, but also strongly upregulated in our microarray analysis. Three members of the MIR449 family embedded in the CDC20B gene are expressed during, and required for, MCC differentiation 17 . Thus, MCI lies in a genomic region that seems to have evolved to play a major role in MCC formation.
MCI RNA expression in Xenopus embryos presages other markers of MCC differentiation, including foxj1 and α-tubulin (ref. 7 ; Supplementary Fig. S1c -e, data not shown), occurring in a spotty pattern that correlates best with MCCs rather than other differentiated cell types [18] [19] [20] . MCI expression is lost by stage 26, when MCCs in the skin are fully differentiated, but is then detected in the developing nephrostomes of the kidneys where MCCs form at later stages ( Supplementary Fig. S1f,g) . Consistent with the microarray results, MCI RNA expression in the skin is inversely affected by the levels of Notch signalling ( Supplementary Fig. S1n,o) . Thus, expression of MCI RNA is transiently detected in epithelia with differentiating MCCs in a Notch-regulated manner.
Knockdown of MCI activity inhibits the formation of MCCs in the skin
To examine MCI function in skin development, we injected embryos with a morpholino (MCI-MO spl ) designed to target and inhibit splicing of the MCI preRNA (ref. 21 ). Splicing of endogenous MCI RNA was inhibited in morphants, as predicted, resulting in MCI transcripts that should encode a truncated MCI protein ( Supplementary Fig. S2a ). Specificity of the morphant phenotype was verified by a rescue experiment ( Supplementary Fig. S2d-f ), and by identical phenotypes obtained with dominant-negative MCI mutants (see below). A second MCI morpholino targeting the MCI start site proved less effective, indicating that it only partially blocked MCI function ( Supplementary Fig. S2b ,c,g).
MCI-MO spl morphants developed normally on the basis of external morphology, but completely lacked MCCs in the skin according to cilia staining ( Fig. 1b versus Fig. 1a ). MCI morphants also lacked other features of MCCs, such as multiple centrioles, indicating an early block in MCC differentiation, not just a block in basal-body docking as seen in foxj1 morphants 7 (Fig. 1c-f ). MCCs first arise as precursors within the basal layer of the ectoderm, and differentiate by intercalating into the outer layer, along with an equal number of precursors for proton-secreting cells 19, 22 (PSCs) . In MCI-MO spl morphants, the total number of intercalating cells decreased by half, with only intercalating PSCs evident, consistent with a selective loss of MCC precursors (Fig. 1i,j) . In addition, PSC numbers and subtypes were unchanged in MCI morphants compared to controls ( Supplementary Fig. S3a-e ). Thus, in the absence of MCI, epithelial progenitors fail selectively to give rise to MCCs, most likely remaining as undifferentiated basal cells.
MCI induces ectopic MCC differentiation
To determine whether MCI can promote MCC differentiation, myc-tagged MCI (MT-MCI) was mis-expressed in embryos by RNA injection (Fig. 2b) . At high levels, injection of MT-MCI RNA was toxic, whereas at lower concentrations, injected embryos survived past gastrulation and showed two phenotypes ( Fig. 2b versus Fig. 2a ). In one phenotype, the outer epithelial cells were in some cases 2-4 times 11.5 (d) , and then fixed at stage 28 and stained for cilia (green). (e-g) The outer epithelium from donor embryos injected with mRFP RNA (red) was transplanted onto host embryos injected with mGFP RNA (green), as illustrated in Fig. 1g . Host (f) and donor (g) embryos were also injected with MCI-HGR RNA. Embryos were treated with DEX at stage 11.5 and fixed at stage 28. Shown are confocal micrographs of a control transplant (e), a transplant onto a host injected with MCI-HGR RNA (f) and a transplant from a donor injected with MCI-HGR RNA (g), after staining for cilia (blue). (h) Cell types in the skin were scored as MCCs (green with blue cilia staining), PSCs (green with no cilia staining), outer cells (red) or outer cells with cilia (red with blue cilia). Data are presented as an average of 10-15 fields (±s.d.) obtained from at least three transplants and the asterisks denote experimental values significantly different from control values (P < .005). Scale bars, 20 µm. larger than normal and when extreme in size, non-ciliated, and in the other phenotype, the number of MCCs increased markedly. As the apical size of the epithelial cells decreases in the early embryo through stage 10 without cell growth ( Supplementary Fig. S4a ), the former result indicates that ectopic MCI induces very early cell-cycle exit (see below). The latter result indicates that MCI is sufficient to promote MCC differentiation.
MCI toxicity at early developmental stages led us to generate a glucocorticoid-inducible form (MCI-HGR), by fusion to the ligandbinding domain from human NR3C1 (ref. 23 ). Embryos injected with MCI -HGR RNA developed normally in the absence of dexamethasone (DEX; Fig. 2c ). However, when MCI -HGR-expressing embryos were treated with DEX at the beginning of gastrulation, MCC differentiation was broadly induced across the skin (Fig. 2d ), resulting in areas where all of the cells were multiciliated. The skin cell types that respond to MCI were determined by restricting MCI-HGR to different layers of the ectoderm (Fig. 1g ). When confined to the outer layer, MCI-HGR efficiently induced MCCs but had little or no effect on the number of MCCs and PSCs derived from the underlying basal layer (Fig. 2g,h) . Conversely, when MCI-HGR was expressed in just the basal layer, the number of intercalating MCCs increased at least threefold, the number of PSCs dropped and the outer cells in the transplant remained unciliated (Fig. 2f,h) . Thus, MCI-HGR induces MCC differentiation in a layer-autonomous fashion, including ectopically in the outer epithelium. In addition, MCI can inhibit PSC intercalation ( Fig. 2h ) and decrease the number of cells expressing PSC markers ( Supplementary Fig. S3f -k), indicating that it can redirect cell fate. However, the number of PSCs did not increase in MCI morphants ( Fig. 1j ), indicating that MCC and PSC fates are normally established independently.
MCI promotes MCC differentiation downstream of notch by coordinately activating several pathways
The results above indicate that MCI may act as a cell fate switch that allows progenitor cells to overcome lateral inhibition and form an MCC. We examined this possibility further by expressing different concentrations of MCI -HGR RNA along with RNA encoding an activated form of notch, the intracellular domain (ICD). Under conditions where ICD efficiently represses endogenous MCC differentiation ( Fig. 3c ,f), ectopic MCC differentiation was still induced by a high concentration of MCI -HGR RNA (Fig. 3b,f) . At a lower concentration of MCI -HGR, however, ICD regained inhibitory activity, reducing the number of ectopic MCCs twofold ( Fig. 3e,f ). Significantly, under these conditions, a fraction of MCCs induced by MCI-HGR failed to complete differentiation, resulting in cells that extend a single cilium but do not assemble centrioles, whereas in others, centriole assembly occurred but axoneme elongation failed ( Fig. 3e ). Thus, MCI acts downstream of notch to promote MCC formation, but notch inhibits MCI expression and its ability to promote different aspects of the differentiation process, including centriole assembly and motile cilia extension. MCI promotes both processes cell autonomously, according to the analysis of MCI-expressing clones ( Supplementary Fig.  S4b-e ). Furthermore, when MCI-HGR is expressed along with a foxj1 morpholino 7 , MCI still induces centriole formation, but ciliogenesis Figure 3 MCI acts downstream of notch to promote centriole assembly and motile cilia extension through foxj1. (a-e) Confocal micrographs of the skin of embryos injected with varying amounts of MCI-HGR RNA (a,d), ICD RNA (c) or both RNAs (b,e), along with mRFP (red) and Centrin4-GFP RNA (green) as a tracer and to mark centrioles, respectively. Embryos were treated with DEX at stage 11.5, fixed at stage 28 and stained for acetylated tubulin to visualize cilia (blue). In embryos injected with ICD and 37 pg of MCI-HGR RNA (e), MCC differentiation was sometimes incomplete, resulting in cells extending cilia but failing to undergo centriole assembly (arrowhead) or vice versa (arrow). Average number of centrioles (lower right, ±s.d.) is statistically the same with or without ICD at 150 pg of MCI-HGR but different at 37 pg of MCI-HGR RNA (P = 6 × 10 −6 ). Scale bars, 20 µm. (f) The average percentage of MCCs per field (±s.d.) plotted on the basis of data obtained from three fields from four embryos (n = 12). Values marked with an asterisk are highly significant (P < .005). (g,h) Confocal micrographs of the skin of embryos injected with MCI-HGR, centrin4-RFP and mRFP RNAs, followed by a foxj1 (h; ref. 7) or a control morpholino (MO Cont ; g). Embryos were treated with DEX at stage 11.5, fixed at stage 28 and stained for acetylated tubulin to label cilia (green). Scale bars, 20 µm. (i) Cilium number per cell was scored from two fields from five embryos (n = 10) for each condition, and plotted as the average fraction of cells (±s.d.) with different cilium number as indicated per field.
is severely disrupted, to the same extent as that seen in the MCCs of foxj1 morphants ( Fig. 3g -i), indicating that MCI induces motile cilia outgrowth through foxj1.
MCI induces cell-cycle exit and centriole assembly
The molecular pathway that induces centriole assembly in dividing cells is activated during the G1/S transition. In contrast, centriole assembly in MCCs occurs postmitotically. We therefore investigated whether MCI activity drives cell-cycle exit, using ethynyl deoxyuridine (EdU) labelling to score the proportion of cells in the outer layer that still cycle after inducing MCI-HGR activity with DEX. The results show that MCI-HGR caused a marked decrease in EdU labelling within 1-3 h after DEX induction, indicating that MCI activity rapidly induces cell-cycle exit ( Supplementary Fig. S4f -h).
Centriole assembly in MCCs is poorly characterized molecularly but is known to occur at deuterosomes 24 . To determine whether MCI induces centriole assembly through similar structures, we scored foci of sas6-GFP, a protein that seeds new centrioles when they multiply in MCCs (ref. 25) . In control embryos, a sas6-GFP tracer lightly labels centrioles in outer layer cells as well as basal bodies in MCCs ( Fig. 4a-e ). In contrast, in embryos injected with MCI -HGR RNA, numerous, large, bright foci of sas6-GFP form in outer cells, starting approximately 4-6 h after the addition of DEX, or slightly after cell-cycle exit, as measured above ( Fig. 4f-k) . The formation of these foci peaks 8 h after DEX addition, before dispersing into a large number of centrioles/basal bodies at 10 h ( Fig. 4j ). When MCI-HGR-injected embryos are fixed and imaged by transmission electron microscopy 8 h after DEX addition, centriole assembly sites with the same morphology as deuterosomes are detected in outer cells ( Fig. 4l ). Centriole assembly induced by MCI is efficient, ultimately resulting in approximately the same number as that found in endogenous MCCs ( Fig. 4m-o) , with a similar distribution around the mean, and with proper polarity along the anterior-posterior axis ( Supplementary Fig. S4i -l). These findings strongly indicate that MCI induces centriole assembly and basal body formation by the same mechanism operating in MCCs.
MCI is a direct regulator of MCC gene expression
MCI could mediate a cell fate switch by activating gene expression required for MCC differentiation, a possibility consistent with the response of MCI-HGR to DEX treatment, and the nuclear localization of ectopically expressed, tagged forms of MCI ( Supplementary  Fig. S5a,b ), similar to human IDAS (ref. 14) . Indeed, the expression of foxj1 and α-tubulin was lost in embryos injected with MCI-MO spl (Fig. 5b ,f) and conversely, markedly upregulated in embryos injected with MCI -HGR RNA (Fig. 5d,h) . The response to MCI is likely to be mediated through the proximal promoters of these genes, because MCI-HGR also induced the expression of transgenes containing GFP driven by 1.5 kilobases (kb) of genomic DNA lying upstream of the translation start site in the foxj1 or α-tubulin genes 22 ( Supplementary Fig. S5c-j) .
We next used quantitative RT-PCR to analyse MCI transcriptional activity in animal cap assays. MCI-HGR strongly induced foxj1 and α-tubulin expression in animal caps even in the presence of ICD, as described above (Fig. 5i ). We then used microarrays to compare RNA expression in animal caps injected with ICD RNA alone, with that in animal caps injected with both ICD and MCI -HGR RNAs ( Supplementary Table S2 ). As expected, genes upregulated by MCI-HGR included foxj1 and α-tubulin, as well as those previously shown in microarrays to be induced in animal caps by foxj1 (for example, tektins, ccdc78; ref. 7) . MCI also induced genes already known to be expressed in MCCs but poorly characterized functionally (for example, sox7 ; ref. 26) , genes potentially involved in MCC differentiation on the basis of encoded structural motifs (for example, ccdc45, ccdc52) and genes encoding centriole components (for example, cep76 ). Genes identified in this microarray analysis need to be validated (as shown above for foxj1 and α-tubulin), but are consistent with the model that MCI selectively activates gene expression required for MCC differentiation, but not for other cell types, including PSCs ( Supplementary Fig. S3f -h). We next investigated whether MCI activates MCC gene expression directly. In embryos injected with MCI -HGR RNA treated with DEX at stage 10.5, induction of α-tubulin expression occurs rapidly, within 1 h ( Fig. 5l , data not shown). Cycloheximide (CHX) treatment of control embryos between stage 11 and 12 blocks the onset of endogenous α-tubulin expression ( Fig. 5k ). In embryos injected with MCI-HGR, however, α-tubulin expression was still strongly activated in the presence of CHX, when DEX was added after the first hour of treatment ( Fig. 5m ). foxj1 expression was also induced by MCI-HGR following 1 h of DEX treatment (data not shown), indicating the MCI may directly regulate the genes required for MCC differentiation in parallel.
As MCI localizes to the nucleus and rapidly activates gene expression, we investigated whether MCI behaves as a transcriptional activator or repressor when recruited to DNA. MCI was fused to the DNA-binding domain of Gal4 and co-transfected into HEK293 cells along with a plasmid containing UAS-binding sites upstream of a luciferase reporter. In this assay, MCI strongly activated transcription of the reporter gene at least 10-100-fold over the basal level of transcription ( Supplementary  Fig. S5k ), whereas gmnn, as a control, had no significant activity. Deletion mutants of MCI tested in this assay indicate that the transcriptional activation domain is not discrete, but distributed over several regions ( Supplementary Fig. S5k ).
Structural features of MCI required for MCC differentiation
To gain further insight into how MCI functions molecularly, we mapped the domains in MCI required for MCC differentiation using deletion constructs ( Supplementary Fig. S6a ). An MCI mutant lacking the coiled-coil domain (MCI 180-213 ) not only failed to induce MCC differentiation, but instead blocked both the appearance or alone as a control (c,g). RNA-injected embryos were treated with DEX at stage 11.5, and all embryos were fixed at stage 26, and stained with X-gal (light blue). Scale bar, 0.5 mm. Insets show a higher magnification. (i) Animal caps were isolated at stage 10 from embryos injected with ICD RNA, MCI-HGR RNA (MCI) or the two RNAs together, treated with DEX at stage 11, and extracted for total RNA at stage 12, approximately 2 h later. Shown is the log level of expression (±s.d.) relative to ICD values set at zero, as measured in triplicate using quantitative rt-PCR and after normalization against a ubiquitously expressed RNA, odc. (j-m) Single animal blastomeres were injected with MCI-HGR RNA at the two-cell stage. At stage 11, half of the injected and un-injected control embryos were treated with CHX for 1 h, and then additionally treated with DEX for another 1 h to induce MCI-HGR activity. CHX is sufficient to block the onset of α-tubulin expression in the controls (compare k with j), indicating that the CHX treatment is effective, but does not block the activation of α-tubulin by MCI-HGR (m). Scale bar, 0.2 mm. Insets show a higher magnification.
of MCCs in the skin and the expression of foxj1 and α-tubulin Supplementary  Fig. S6b ,n,s, data not shown) showed that a 40-amino-acid domain at the carboxy terminus, termed CT, is sufficient to generate this strong dominant-negative phenotype, and thus essential for MCI function.
In agreement with this interpretation, a form of MCI lacking CT (MCI 334-374 ) failed to induce ectopic MCC differentiation ( Fig. 6i and Supplementary Fig. S6f ) but did induce the large-cell phenotype and reduced EdU incorporation, consistent with premature cell-cycle arrest ( Supplementary Fig. 6g -j), as did a form containing just the coiled-coil domain (data not shown). MCI 334-374 did not qualitatively change the expression of the PSC marker, foxi1, or the MCC markers, foxj1 and α-tubulin ( Fig. 6e and Supplementary Fig. S6o ,t), but did cause weak ciliogenesis defects ( Fig. 6i ). In sum, both the coiled-coil and carboxy-terminal domain are required for MCI to function as a transcriptional regulator during MCC differentiation. The former domain can induce cell-cycle exit but not MCC gene expression and the latter is a potent specific inhibitor of MCC differentiation.
MCI is required for MCC differentiation in diverse epithelia
We next investigated whether MCI function is required for other cells to form motile cilia. In Xenopus, motile monociliated cells that mediate left-right patterning arise on the gastrocoel roof plate (GRP) during gastrulation and extend cilia before the MCCs in the skin 27 . MCI RNA was not detectable in the superficial mesoderm that gives rise to the GRP (data not shown). Moreover, when MCI-MO spl or the potent MCI dominant-negative mutant was targeted to the mesoderm, motile cilia still appeared on the GRP ( Supplementary Fig. S7a -e), indicating that MCI is not required for motile cilium formation per se, but only when multiple motile cilia form per cell.
We next determined whether MCI is required when MCCs form within epithelia derived from other germ layers. MCI is expressed in Xenopus embryos in the developing nephrostomes, a derivative of the lateral mesoderm ( Supplementary Fig. S1 ). In MCI morphants, the formation of MCCs within the kidney seems to be blocked according to α-tubulin expression, whereas in MCI-HGR-injected embryos, α-tubulin expression was expanded both in the kidney as well as ectopically into neighbouring tissues ( Supplementary Fig. S7f -i).
We also examined the expression and function of MCI in primary cultures of mouse tracheal epithelial cells (MTECs), in which MCC differentiation is promoted by exposure to an air-liquid interface 28 (ALI). On the basis of semi-quantitative RT-PCR, expression of mouse MCI (PubmedGene ID 622408) RNA markedly increases in MTEC cultures closely following the time course of MCC differentiation 25 ( Supplementary Fig. S8a ). We next used lentiviral gene transfer to introduce either a myc-tagged form of full-length mouse MCI (MT-MCI) or a dominant-negative form that lacks the coiled-coil Supplementary Fig. S8f ), indicating that MCI is required downstream of Notch regulation to promote MCC differentiation, as shown above in Xenopus skin.
DISCUSSION
Our results identify MCI as a key regulator of MCC differentiation on the basis of its ability to coordinately promote cell-cycle exit, deuterosome-mediated centriole assembly, and Foxj1 expression ( Supplementary Fig. S9 ). MCI functions in developing epithelia derived from all three germ layers, ranging from Xenopus skin and kidney to mouse trachea, indicating that MCC differentiation is driven in epithelial progenitors by an MCI-mediated program regardless of embryonic lineage. As MCI is positioned at the top of a hierarchy that directs epithelial progenitors into the MCC fate, mechanisms that promote or inhibit MCC precursor formation are likely to target MCI. An example of the latter is the Notch pathway, which restricts MCC differentiation in a variety of tissues and species [11] [12] [13] 29, 30 , and which we show here represses MCI expression and activity. Identification of MCI, therefore, is an important step towards determining how MCCs are selected out by Notch, how they are programmed to differentiate and for exploring how these cells are lost in disease states and restored during tissue repair.
One implication of our findings is that MCI determines cell fate not as a sequence-specific DNA-binding protein as in most cases, but rather as a scaffolding protein that is cell-type specific in expression and action. MCI presumably acts in a multi-protein complex that could conceivably function on or off DNA but is necessary and sufficient to activate gene expression associated with MCC differentiation. MCI may also function in part through its ability to heterodimerize with gmnn (ref. 14) , a dual-function protein that acts broadly to inhibit embryonic gene expression associated with differentiation 31 . Indeed, overexpressing gmnn in embryos does not induce MCC formation but inhibits their differentiation (data not shown) 31 . However, MCI is unlikely to act solely as a gmnn inhibitor, because the coiled-coil domain of MCI, which is sufficient to bind gmnn (ref. 14; data not shown), does not promote MCC formation. Moreover, MCI activates only MCC gene expression, a small subset of the embryonic gene expression inhibited by gmnn (ref. 31 ). Thus, identification of additional binding partners for MCI is likely to be an essential step in revealing how MCI activates the genes required to acquire the MCC fate.
Centriole assembly in MCCs occurs through two pathways: approximately 10% of the centrioles form orthogonally to an existing centriole, much like in dividing cells; however, most assemble around deuterosomes 24 . The centriolar pathway could be driven by increased expression of factors that initiate centriole assembly at the G1/S transition, which can modestly amplify centriole number when overexpressed [32] [33] [34] [35] [36] . Our findings indicate that the acentriolar pathway may be driven by MCI, as evidenced by its ability to induce the appearance of ectopic deuterosomes ( Fig. 4l ), resulting in the appropriate centriole number (Fig. 4o ). As this response correlates with the ability of MCI to activate transcription, we also suggest that MCI transcriptional targets are directly involved in initiating centriole assembly through the deuterosome-mediated, acentriolar pathway. Further characterization of these targets, therefore, will probably * * identify an alternative centriole assembly pathway that underlies this striking example of organelle biogenesis.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology 37, 38 . Total RNA was isolated using the proteinase K method from ectoderm explanted at stage 10, and collected at the equivalent of stage 12. Total RNA was used to generate labelled complimentary RNA (cRNA) that was hybridized to X. laevis v2 Genome Array chips (Affymetrix #901214). Microarray data were obtained from two independent experiments in which embryos were injected with ICD RNA alone, and two independent experiments in which embryos were injected with either dominant-negative rbpj or dominant-negative HMM RNA. These data sets were analysed using Bullfrog analysis software using a pair-wise comparison, with the minimum fold change set at 3 (ref. 39 ). The top gene upregulated (168-fold) when Notch was blocked versus activated corresponds to UnigeneXl.55698. Microarray data have been submitted to GEO (GSE32331). Analysis of MCI-HGR-regulated genes was carried out as described above, except that embryos were injected with both MCI -HGR and ICD RNAs, or with ICD RNA alone. Isolated caps were treated with DEX at stage 11 and then collected 4 h later for analysis. RNA templates for the deletion mutations of MCI were generated in the CS2-MT vector using restriction sites or PCR, followed by sequencing. An RNA template for MCI-HGR was constructed by fusing sequences encoding the ligand-binding domain of the HGR to the MT-MCI carboxy terminus 23 . Templates for generating synthetic RNA encoding hyls1-GFP, MT-ICD, centrin4-RFP, clamp-GFP, mGFP or mRFP in vitro have been described previously 7, 22, 41, 42 .
Constructs. A
A cDNA encoding mouse MCI was obtained from the Riken mouse FANTOM clone library (clone ID 5830438C23). Both the full-length mouse MCI, and a form lacking the coiled-coil domain (MT-MCI CC, 175-238) were generated by PCR, sequenced and inserted downstream of the six myc tags in CS2. Sequences encoding MT-MCI and MT-MCI CC were transferred into the pRRL.sin-18.PPT.PGK.GFP.pre vector 25, 43 , and used to generate lentiviruses using previously described protocols 25 .
X. laevis fertilizations and micro-injections.
Xenopus embryos were obtained by in vitro fertilization using standard protocols 44 . Embryos were injected at the two-cell stage with capped, synthetic messenger RNAs, typically using 1-5 ng per embryo. Morpholinos (Genetools) directed against MCI RNA targeted the initiation codon ( Supplementary Table S1 ), or the splice donor site at the junction between exon 5 and intron 5 ( Supplementary Table S1 ). The foxj1 morpholino has been described previously 7 . Efficacy of the splicing morpholino was assayed using semi-quantitative RT-PCR ( Supplementary Fig. S2 ). Unless indicated otherwise, embryos were injected with 40-50 ng of morpholino.
In situ hybridization and immunofluorescence microscopy. Whole-mount, in situ hybridizations were carried out in embryos injected with RNAs or morpholinos where the injected side was marked by a lacZ RNA tracer and stained with X-gal, as described previously 7 . RNA probes to detect Xenopus α-tubulin, foxj1, foxi1, ae1 and pendrin-like were previously described 7, 19 and the MCI probe consisted of just the coding region.
Embryos were fixed quickly for visualization of GFP fusion proteins and actin staining with phalloidin using a formaldehyde-and gluteraldehyde-based quick fix 7 . For antibody staining, embryos were fixed in 4% paraformaldehyde in phosphate buffered saline (PBS) for 1 h on ice followed by dehydration in 100% ethanol. In the case of the GRP, dorsal explants were placed underneath a glass coverslip just before fixation, to flatten out the curvature of the GRP and to press the cilia against the cell surface for measurement 7 . Fixed tissues were rehydrated, washed with PBS containing 0.1% Triton X-100 (PBT) and blocked with PBT containing 10% heat-inactivated normal goat serum for at least 1 h. Embryos were incubated with primary antibody in blocking solution overnight as follows: rabbit anti-ZO-1 (Zymed 1:200), mouse monoclonal anti-acetylated α-tubulin (Sigma, 1:200-1:1,000), mouse anti-myc (9E10, 1:10), rabbit anti-GFP (Molecular Probes, 1:1,000) or rabbit anti-dsRed (Clontech 1:1,000). After washing, embryos were incubated overnight in Cy2-, Cy3-or Cy5-labelled goat anti-IgG of the appropriate species (all used at 1:500, Jackson ImmunoResearch), washed in PBT and then mounted in PVA with DABCO. Mounted embryos were imaged on a BioRad Radiance 2100 confocal system mounted to a Zeiss inverted microscope using a ×25 or ×63 objective. Typically, data were collected from three randomly chosen fields from five embryos using the tracer to detect injected regions. Statistical significance was gauged in all experiments using a two-tailed t -test.
Xenopus transgenics. A 1.5-kb genomic fragment lying upstream of the translational start site in the X. tropicalis foxj1 gene was isolated by PCR, and cloned upstream of GFP using CS2 as the backbone. Foxj1-GFP transgenics were generated employing sperm nuclei transfer as previously described and modified 45, 46 . The α-tubulin-GFP F1 transgenics were generated using sperm nuclei derived from an F0 male as described previously 22 . Transgenic embryos were injected at the two-cell stage with MCI -HGR or foxj1 RNA, along with mRFP as a tracer or as a control, treated with DEX at stage 11, fixed at stage 26 and then imaged, after staining for cilia using an acetylated antibody.
MTEC cultures, lentiviral manipulation, immunofluorescence microscopy and RT-PCR. MTECs were cultured from wild-type C57BL/6J (The Jackson Laboratory) mice of six weeks of age or older, as previously described 25 . All procedures involving animals were approved by the Institutional Animal Care and Use Committee in accordance with established guidelines for animal care. In short, airway epithelial cells were isolated from trachea by protease digestion, contaminating fibroblasts were removed by preplating the suspension and the remaining, unadhered epithelial cells were seeded onto collagen-coated Transwell-Clear permeable membranes (Corning). Cells were grown in MTEC complete medium 28 until an ALI was created approximately 2 days after confluence by adding MTEC basal medium + 2% NuSerum 28 . Beating cilia were observed by phase microscopy 3 days after ALI creation. To block Notch activity, MTECs were treated with 1 µM DAPT in ALI media for 72 h from ALI + day 1 to day 4. Lentivirus production and infection of MTECs were carried out as previously described 25 . In short, lentivirus expressing GFP or MT-MCI cDNA was produced by transient co-transfection of HEK293T/17 cells (ATCC) with the lentiviral transfer vector pRRL.sin-18.PPT.PGK.GFP.pre (ref. 43 ) and helper vectors (pCMVDR8.74 packaging vector and pMD2.VSVG-envelope vector) 47 using the calcium phosphate co-precipitation method. The lentiviral supernatant was concentrated by centrifugation to achieve 10 7 -10 8 infectious units per millilitre. To infect MTECs, tight junctions were first disrupted by EGTA treatment, and then cells were spin infected with lentivirus. For indirect immunofluorescence microscopy, MTECs were fixed in 4% paraformaldehyde at room temperature for 10 min, and then filters were excised from plastic supports. Samples were blocked in 10% normal horse serum (Invitrogen) and 0.1% Triton X-100 in PBS for 1 h at room temperature. Primary antibodies were applied to filters at 37 • C for 1 h: Foxj1 (1:500, eBioscience), pericentrin (1:250, Abcam), myc (1:200, A14, Santa Cruz) and E-cadherin (1:250, ECCD-2, Invitrogen). Alexa dye-conjugated secondary antibodies (1:250, Invitrogen) were applied to filters at room temperature for 30 min. Filters were mounted with 12 mm #1.5 coverslips (Erie Scientific) using Mowiol mounting medium containing N -propyl gallate (Sigma). For RT-PCR, RNA was extracted from MTECs using the Qiagen RNeasy Mini kit (Qiagen) after cells were treated with a 1:1 mix of non-enzymatic cell dissociation solution (Sigma) and 0.5% trypsin (Invitrogen) for 20 min. cDNA was generated using the SuperScript III First Strand Synthesis kit (Invitrogen) and used to amplify GAPDH (control) and MCI.
Quantitative RT-PCR. Embryos were injected at the two-cell stage with ICD and/or MCI -HGR RNA. Animal caps were dissected at stage 10, treated with DEX at stage 11 and then collected for total RNA extraction at stage 13. cDNA templates were generated from 3 µg of RNA using SuperScript III Reverse Transcriptase (Invitrogen). Quantitative RT-PCR reactions were carried out using the ABI Prism 7900HT Thermal Cycler, using primers for foxj1 and α-tubulin or for ornithine decarboxylase (odc) as a normalization control ( Supplementary Table S1 ). Data were analysed using Applied Biosystems Sequence Detection System software.
EdU assays. Embryos were injected at the two-cell stage with MCI -HGR and mRFP RNA or mRFP RNA alone. DEX was added to embryos at mid-gastrula stages. At 1 h, 3 h or 7 h after the addition of DEX, embryos were injected four times (10 nl per injection) into the gastrocoel with 10 mM EdU (Invitrogen). Embryos were allowed to develop until stage 28, fixed for 1 h in 3.7% formaldehyde in 1× PBS and then dehydrated in ethanol. Embryos were stained using the Invitrogen Click-iT Alexa 488 kit (Invitrogen C10337). Briefly, embryos were rehydrated in PBT (1× PBS with 0.5% Triton X-100). Embryos were permeabilized by washing for 1 h in PBT at room temperature and then incubated for 1 h in EdU reaction buffer made up as per the kit instructions. Embryos were washed several times in PBT, then mounted in PVA/DABCO and imaged as for other staining procedures.
Reporter assays. HEK293 cells were co-transfected with 140 ng of firefly luciferase reporter construct (Promega pGL4.23 #E4811) and 150 ng of expression constructs where MCI fragments were cloned in frame with the Gal4 DNA-binding domain in the pCMV-BD vector (Agilent #211342). Cells were transfected in 48-well plates using FuGENE 6 (Roche #1181443001) together with 10 ng of the Renilla luciferase pGL4.74 plasmid (Promega #E6921) as a transfection efficiency control. Firefly and Renilla luciferase activity was measured 40-48 h after transfection, using the Dual-Glo Luciferase Assay System (Promega #E2920). Values are mean ± standard deviation for three individual experiments.
Transmission electron microscopy. Embryos were fixed in 2% glutaraldehyde in 0.1 M sodium cacodylate buffer, rinsed, post-fixed in 1% osmium tetroxide and 1% potassium ferrocyanide, rinsed, en bloc stained in 1% uranyl acetate, dehydrated with glycol methacrylate and embedded in Epon. Thin sections (∼60 nm) were cut on an ultramicrotome, collected onto formvar-coated slot grids and stained with 2% uranyl acetate and 0.2% lead citrate. The sections were examined at 80 kV in a Zeiss Libra 120 PLUS EF-TEM transmission electron microscope. DOI: 10.1038/ncb2406 Figure S1 MCI genes and expression in Xenopus embryos. (a) Xenopus MCI is a small protein most related to Geminin and GEMC1, based on homology within a central coiled-coil domain. (b) Shown is the region of chromosome 5 of the human genome with genomic synteny to the region where the MCI gene lies in mouse and Xenopus. (c-g) Expression of MCI in Xenopus embryos was detected at different developmental stages using whole-mount in situ hybridization. Shown in each case is both a low power view of the whole embryo and an inset at higher power. Expression is first detected during gastrulation (c, BPL=blastopore lip) in a spotty pattern within the prospective epidermis. Expression is excluded from the neural plate (d,np=neural plate) at stage 13 (d) and covers the skin regions where MCCs are known to form by stage 16 (e). The pattern of MCI expression in the skin best correlates with MCCs, rather than the mucus-secreting cells that comprise most of the outer epithelium, or a second scattered population of proton secreting cells (PSCs) [18] [19] [20] . MCI expression is lost in most of the skin by stage 26 (f) when MCCs are differentiated, but is re-expressed in the developing nephrostomes of the kidney (g, arrowhead). (h,i) Shown is a-tubulin expression, a marker of MCCs in the skin, and in the nephrostomes of the kidney (i, arrowhead).
(j-o) Embryos were injected twice in the animal pole of one blastomere at the two-cell stage with RNA encoding the intracellular domain of Notch (ICD) to activate Notch signaling (k,n), RNA encoding the DNA-binding mutant of Su(H) (dnSu(H)) to block Notch signaling (l,o), along with LacZ RNA as a tracer, or as a control (j,m). Embryos were fixed at stage 13, stained with Xgal (light blue reaction product) and then processed for whole mount in situ hybridization for the expression of a-tubulin (left panels) or MCI RNA (right panels). Shown in each case are the injected and uninjected (prime) sides of representative embryos with an insert at higher power. Similar results were obtained for at least twenty embryos in each case. Scale bars=0.5mm 4) . (b-c) Embryos were injected with a control morpholino (b) or MCI-MO ATG (c), fixed at stage 28 and stained with antibodies against ZO-1 (red) and acetylated a-tubulin (green). MCI MO ATG injections result in ciliogenesis defects (arrows in c). (d-f) Rescue experiment: a batch of embryos injected with MCI-MO Spl , were divided in two, half of which were also injected with RNA encoding MCI-HGR (f). Control embryos (d) and morphants (e,f) were also injected with RNA encoding mRFP (red) or Hysl-GFP (green), to label membranes and centrioles, respectively . Shown are confocal images of the skin after embryos were treated with DEX at stage 11.5, fixed at stage 26 and stained for cilia (blue). The average number of MCCs present per field is shown in the lower left corner (average of ten fields from 5 embryos ± s.d) and the average number of centrioles per MCC is shown in the right (average of ten cells from 5 embryos ± s.d). While the reduction of MCCs in response to the MCI morpholino is highly significant (p=9x10 -11 ), the number of centrioles following rescue by MCI is statistically the same. 
Figure S3
MCI activity is not required for PSC differentiation. (a-d) Embryos were injected with a control morpholino or the MCI splicing morpholino, fixed at stage 28 and then stained with antibodies against AE1 (a,c), or with antibodies to E-cadherin (green) and to ATP6V1B1 (red) (b,d). ATP6V1B1 staining identifies all PSCs in the skin, while AE1 identifies a subset analogous to alpha-intercalated cells in the mammalian kidney 19 . Sib embryos stained with an acetylated tubulin antibody to mark cilia showed a predicted loss of MCCs in the MCI morphants (data not shown). Scale bars= 20 microns. (e) Average number of different PSCs subtypes in MCI and control morphants (±s.d.), based on data obtained from 3-5 fields from three different embryos (total n=12). Values are not significant different based on a two-tailed t-test. (f-k) Embryos were injected with MT-MCI RNA (f-h) along with nLacZ RNA as a tracer or as a control (i-k). At stage 24, embryos were fixed, stained with X-gal (light blue) and for the expression of Foxi1, a master regulator of PSC differentiation, pendrin-like, a marker of b-PSCs, and AE1, a marker of a-PSCs, using whole-mount in situ hybridization (dark purple) 19 . Note that MCI does not induce PSC marker gene expression, but may instead reduce PSC number. Scales bars=0.5mm. Figure S4 MCI-HGR promotes different aspects of MCC differentiation. (a) The apical size of the surface epithelial cells at different developmental stages was measured in embryos injected with mRFP RNA, focusing on ectodermal regions that give rise to the developing skin. Shown is a plot of the average size (±.s.d.) based on 30-120 cells from 6-10 embryos. Note that apical size decreases through stage 10, but remains relatively constant thereafter. (b-e) MCI activity was measured in clonal assay in which a small explant of ectodermal tissue was isolated from stage 10 donor embryos injected with MCI-HGR and mRFP RNA, and transplanted onto host embryos injected with ICD and mGFP RNA. Embryos were treated with DEX at stage 11.5, fixed at stage 28, and stained with an acetylated tubulin antibody (blue) to identify MCCs. Shown is a representative transplant at the boundary between donor (b, red), and host (c, green) tissue, showing that all of the MCCs (d, blue) are derived solely from donor cells (e, merge). Scale bars=40microns. (f-h) EdU labeling of cycling cells was measured after inducing MCI-HGR activity. Embryos were injected with MCI-HGR RNA along with RNAs encoding mRFP and H2A-Cherry as a tracer or as a control, to stain membranes and nuclei, respectively. At stage 11, embryos were induced with DEX to induce MCI activity, and then pulsed with EdU at 1, 3 or 7 hrs later. At stage 28, embryos were fixed, stained for EdU incorporation (green) and then imaged by confocal microscopy. Shown is a representative image from a control (f) or MCI-HGR (g) injected embryo pulsed with EdU 1 hr after DEX treatment. Plot (h) showing the fraction nuclei labeled with EdU (±s.d.) at each condition based on data obtained from 16-20 fields from at least ten different embryos. All MCI-HGR values are significantly different from control values (p<.005) (i-l) Basal body orientation was measured in MCCs induced by MCI-HGR. Embryos were injected with CLAMP-GFP and Centrin4-RFP RNA alone (i) or with MCI-HGR RNA (k). At stage 11.5, the embryos were treated with Dex, and then fixed at stage 28 to visualize Centrin4-RFP (red), which localizes to the basal body, and Clamp-GFP (green), which localizes to the rootlet. Shown are representative images. Scale bars=10 microns. Basal body orientation was scored by drawing a line from Clamp-GFP to Centrin-RFP, as described previously (j,l) 42 . Polar plots (j,l) representing the orientation of individual cells in relation to embryonic axis, where different colors represent cells from two different embryos, (A: Anterior, P: Posterior, D: Dorsal) (see 42 for details) Figure S5 MCI is a nuclear protein, regulates transgenic FoxJ1 and a-tubulin expression, and acts as a co-activator. (a-b) Embryos were injected with RNAs encoding a myc-tagged form of MCI (MT-MCI) and mGFP (green) as a tracer. At stage 10, embryos were fixed, stained with an anti-myc antibody (red), and imaged by confocal microscopy. Scale bar=20microns. (c-j) Transgenic embryos were generated with the sperm nuclei transfer method, using proximal genomic sequences from a-tubulin (c-f) or FoxJ1 (g-j) to drive mGFP expression. At the two cell stage, embryos were also injected with RNA encoding MCI-HGR along with mRFP RNA as a tracer (e,f,I,j) or as a control (c,d,g,h). Embryos were treated with DEX at stage 11.5, fixed at stage 26, and then stained with antibodies to GFP (green) or to acetylated tubulin (blue) to label cilia. Shown are representative regions of skin labeled with the RFP tracer (not shown) imaged by confocal microscopy. Scale bar=10 microns. Note that both transgenic drivers express GFP only in MCCs and can be induced ectopically by MCI-HGR. In other experiments, neither transgene responds to FoxJ1 RNA injection (data not shown). (b) Embryos were injected with RNAs encoding wildtype or MCI deletion mutants, fixed at stage 28 and stained with Z0-1 and acetylated tubulin antibodies to label cell boundaries and cilia, respectively (See Figure 6b -e in the main text). Outer cells (OCs), MCCs and PSCs were scored from two fields from five embryos (n=10) based on cilia staining and morphology, and plotted as the average number (±s.d.) per field. Data significantly different from controls are marked (*p<.005). (c,d) Outer layer tissue from mRFP injected embryos was transplanted onto hosts injected with just mGFP RNA (c) or with both mGFP and MCIΔ180-213 RNA (d) as shown in Fig. 1g of the main text. Shown are confocal images of the skin in embryos fixed at stage 26, and stained for cilia (blue). Scale bar (b)=10 microns (e) Plot showing the average number (±s.d.) of OCs (red), MCCs (green/blue) and PSCs (green) per field based on three fields from five transplants (n=15). The reduction of MCCs is highly significant (asterisk: p<0.005) while PSCs are unchanged. (f) Embryos were injected with RNA encoding mRFP, along with different amounts of RNA encoding MCID334-374 as indicated, fixed at stage 28, and stained with an acetylated tubulin antibody (green) to label cilia. The number of outer cells (OC), ciliated cells (CC) and PSCs (small apical domain) was counted for each condition, collecting data from 2 fields from five embryos (n=10), and plotted as the average (± s.d.) cell types detected per field. After correcting for a decrease in cell number, the number of ciliated cells present in MCID334-374 expressing embryos is statistically different from control embryos (p<.005) but the number of PSCs cells is not. (g) Apical size of outer cells was measure under each condition, collecting data from 50 cells from 5 embryos. Error bars=±s.d. All values obtained with MCID334-374 injected embryos are statistically different from control values (t-test, p<.005). (h-j) Embryos were injected with mRFP and H2A-CherryRNA alone or with RNA encoding MCID334-374. At stage 11, embryos were pulsed with EdU, fixed at stage 26 and processed for EdU labeling (green). Shown are confocal images from a control (i) or MCID334-374 RNA injected embryo (j). Scale bar (i)=20microns (h) Plot showing the average number of EdU-labeled nuclei as a fraction of the total under each condition based on data derived from 16-20 fields taken from at least ten different embryos. Error bars=±s.d (k-t) Xenopus embryos were injected in the animal pole of each blastomere at the 4-cell stage with RNA encoding MCI, MCID180-213, MCID69-332, or MCID334-374, as indicated. At stage 13/14, embryos were fixed and stained for FoxJ1 RNA (k-o) or for Foxi1 RNA (p-t), a gene required for PSC differentiation 19, 20 . Shown are representative embryos, with an insert taken at higher power. Note in the case of MCID334-374 that cell size is increased, consistent with a block in cell cycle progression. Scale bars=0.5mm Figure S7 MCI is not required for ciliogenesis on the GRP but is in the kidney. (a-d) Xenopus embryos were injected at the two-cell stage with a control or the MCI splicing morpholino, in the animal pole to target the skin (a,b) or in the marginal zone to target the GRP (c,d). At stage 12, the marginal zone injected embryos were fixed and stained for ZO-1 (red) and acetylated tubulin (green) in order to image cell boundaries and cilia, respectively in the GRP (c,d). At stage 26, the animal pole injected embryos were fixed and stained as above to image cell boundaries (red) and ciliated cell (green) in the skin (a,b). Note the number of ciliated cells in the GRP are unaffected by the MCI morpholino, while those in the skin are completely lost. Scale bars=10microns (e) Cilia length was measure on the GRP in control morphants (cilia, n=400), MCI morphants (n=260) and in embryos injected with a strong dominant-negative MCI mutant lacking the coiled-coil domain (See Fig.6c,g) (n=250). The MCI morpholino and mutant both cause a small decrease in cilia length that is statistically significant (p<3X10 -20 ). Thus, MCI is unlikely to have a major role in GRP cilia formation, but we cannot rule out a very minor contribution to cilia length, given the similar results obtained with the MCI morpholino and the dominant-negative mutant. (f-i) One ventral vegetal blastomere of eight-cell stage embryos was injected to target the prospective marginal zone with MCI-HGR RNA along with lacZ RNA as a tracer (g), or with lacZ RNA alone as a control (f). Embryos were treated with DEX at stage 19/20, and then fixed at stage 30+, stained with X-gal (light blue) to reveal the injected side, and then for a-tubulin expression (dark purple), using whole-mount in situ hybridization. Shown is the injected side of a representative embryo with the region containing the nephrostomes (arrowhead) shown at higher power in the insert. One blastomere of two-cell stage embryos was injected with a MCI-MO Spl (i) or a control morpholino (h), followed by nLacZ RNA to mark the injected region. Embryos were processed for X-gal and a-tubulin staining at stage 30 as above. Scale bars=1mm. 
Figure S9
Model for MCI action during ciliated cell differentiation. Our data suggests strongly that MCI is the critical target of the Notch pathway during lateral inhibition, when MCCs are selected out within ciliated epithelia. When MCI is expressed at high levels, it likely acts as a co-activator that targets, perhaps by direct binding, the proximal response elements in genes required to initiate centriole assembly based on the analysis of a-tubulin. We propose that among the targets of MCI activation, will be those involved in deuterosome-mediated centriole assembly. Importantly MCI also appears to initiate cell cycle exit, thus ensuring that epithelial progenitors only initiate centriole assembly as postmitotic cells. MCI also activates the expression of FoxJ1, a critical regulator for the assembly of motile cilia. Thus, MCI is a pivotal factor that distinguishes multiciliate cells from monociliated cells. 
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